selected scholarly activity
-
academic article
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. New England Journal of Medicine. 379:1107-1117. 2018
- Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 276:98-108. 2018
- Simplified Canadian Definition for Familial Hypercholesterolemia. Canadian Journal of Cardiology. 34:1210-1214. 2018
- Socio-economic, environmental and nutritional characteristics of urban and rural South Indian women in early pregnancy: findings from the South Asian Birth Cohort (START). Public Health Nutrition. 21:1554-1564. 2018
- Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal of Cardiology. 34:506-525. 2018
- Ethnic and diet-related differences in the healthy infant microbiome. Genome Medicine. 9:32. 2017
- Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults (vol 33, pg 557, 2017). Canadian Journal of Cardiology. 33:1733-1734. 2017
- Does the impact of a plant-based diet during pregnancy on birth weight differ by ethnicity? A dietary pattern analysis from a prospective Canadian birth cohort alliance. BMJ Open. 7:e017753-e017753. 2017
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 377:1119-1131. 2017
- Causes and consequences of gestational diabetes in South Asians living in Canada: results from a prospective cohort study. CMAJ Open. 5:E604-E611. 2017
- Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management. Atherosclerosis. 263:112-118. 2017
- Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Canadian Journal of Cardiology. 33:557-576. 2017
- Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9. Canadian Journal of Cardiology. 32:1552-1560. 2016
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology. 32:1263-1282. 2016
- Harmonization of Food-Frequency Questionnaires and Dietary Pattern Analysis in 4 Ethnically Diverse Birth Cohorts. Journal of Nutrition. 146:2343-2350. 2016
- Impactful Clinical Trials of 2015: What Clinicians Need to Know. Canadian Journal of Cardiology. 32:1038.e17-1038.e20. 2016
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016). Canadian Journal of Cardiology. 32:S35-S65. 2016
- Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Canadian Journal of Cardiology. 32:569-588. 2016
- Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry*. Canadian Journal of Cardiology. 32:204-210. 2016
- What accounts for ethnic differences in newborn skinfold thickness comparing South Asians and White Caucasians? Findings from the START and FAMILY Birth Cohorts. International Journal of Obesity. 40:239-244. 2016
- Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials. BMC Surgery. 15:112. 2015
- Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process. Journal of Rheumatology. 42:1548-1555. 2015
- Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice. Eur Heart J Qual Care Clin Outcomes. 1:31-36. 2015
- Contemporary Management and Control of Uncomplicated Hypertension in Canada: Insight From the Primary Care Audit of Global Risk Management (PARADIGM) Study. Canadian Journal of Cardiology. 31:664-670. 2015
- Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia. Canadian Journal of Cardiology. 30:1471-1481. 2014
- Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery Position Statement on Revascularization—Multivessel Coronary Artery Disease. Canadian Journal of Cardiology. 30:1482-1491. 2014
- Coronary Artery Revascularization in Patients With Diabetes Mellitus. Circulation. 130:e104-e106. 2014
- Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease. Canadian Journal of Cardiology. 30:837-849. 2014
- Differences in the Clinical Characteristics of Ethnic Minority Groups With Heart Failure Managed in Specialized Heart Failure Clinics. JACC: Heart Failure. 2:392-399. 2014
- Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel. Canadian Journal of Cardiology. 30:377-380. 2014
- Perioperative cardiovascular system failure in South Asians undergoing cardiopulmonary bypass is associated with prolonged inflammation and increased Toll-like receptor signaling in inflammatory monocytes. Journal of Surgical Research. 187:43-52. 2014
- Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. The Lancet Diabetes and Endocrinology. 1:317-328. 2013
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. Canadian Journal of Cardiology. 29:1553-1568. 2013
- Rationale and design of South Asian Birth Cohort (START): a Canada-India collaborative study. BMC Public Health. 13:79. 2013
- Survey of Diabetes Care in Patients Presenting With Acute Coronary Syndromes in Canada. Canadian Journal of Cardiology. 29:1134-1137. 2013
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis. American Heart Journal. 166:199-207.e15. 2013
- Impactful Clinical Trials of 2012: What Clinicians Need to Know. Canadian Journal of Cardiology. 29:747-750. 2013
- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology. 29:151-167. 2013
- Insulin Resistance and LVH Progression in Patients With Calcific Aortic Stenosis. JACC: Cardiovascular Imaging. 6:165-174. 2013
- Effectiveness of inpatient and outpatient strategies in increasing referral and utilization of cardiac rehabilitation: a prospective, multi-site study. Implementation Science. 7:120. 2012
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome. New England Journal of Medicine. 367:2089-2099. 2012
- Therapeutic Targeting of Inflammation in Atherosclerosis: We Are Getting Closer. Canadian Journal of Cardiology. 28:619-622. 2012
- Impact of Metabolic Syndrome on Progression of Aortic Stenosis. Journal of the American College of Cardiology. 60:216-223. 2012
- Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACT. Journal of Clinical Pharmacology. 52:850-858. 2012
- Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management. Canadian Journal of Cardiology. 28:14-19. 2012
- The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.. Experimental and Clinical Cardiology. 17:191-196. 2012
- Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment Elevation ACS. Canadian Journal of Cardiology. 27:S387-S401. 2011
- Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation Myocardial Infarction. Canadian Journal of Cardiology. 27:S402-S412. 2011
- Altered health status and quality of life in South Asians with coronary artery disease. American Heart Journal. 162:501-506. 2011
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference. Canadian Journal of Cardiology. 27:635-662. 2011
- Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study. European Heart Journal. 32:2135-2142. 2011
- Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group. Canadian Journal of Cardiology. 27:e1-e33. 2011
- Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary). Canadian Journal of Cardiology. 27:124-131. 2011
- Effect of Cardiac Rehabilitation Referral Strategies on Utilization Rates. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 171:235-235. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter. Canadian Journal of Cardiology. 27:60-66. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations. Canadian Journal of Cardiology. 27:31-37. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and Achieving Consensus. Canadian Journal of Cardiology. 27:27-30. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department. Canadian Journal of Cardiology. 27:38-46. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery. Canadian Journal of Cardiology. 27:91-97. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter. Canadian Journal of Cardiology. 27:74-90. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management. Canadian Journal of Cardiology. 27:47-59. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Surgical Therapy. Canadian Journal of Cardiology. 27:67-73. 2011
- Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. American Journal of Physiology - Heart and Circulatory Physiology. 299:H656-H663. 2010
- Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease. Journal of Cardiovascular Pharmacology. 56:241-245. 2010
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. The Lancet. 376:517-523. 2010
- Access to Cardiac Rehabilitation Among South-Asian Patients by Referral Method: A Qualitative Study. Rehabilitation Nursing. 35:106-112. 2010
- Evidence for the efficacy of ARBs across the cardiovascular continuum. Current Medical Research and Opinion. 26:1203-1218. 2010
- A comparison of physical activity environments between South Asians and white Caucasians with coronary heart disease.. Ethnicity and Disease. 20:390-395. 2010
- Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society. Canadian Journal of Cardiology. 25:683-689. 2009
- 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Canadian Journal of Cardiology. 25:567-579. 2009
- Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations. Journal of Clinical Pharmacology. 49:831-837. 2009
- Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. American Journal of Physiology - Endocrinology and Metabolism. 296:E1440-E1449. 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. New England Journal of Medicine. 360:2066-2078. 2009
- Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy. American Heart Journal. 156:1080-1088.e1. 2008
- A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: Study design and protocol. Canadian Journal of Cardiology. 24:S65-S69. 2008
- Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. American Journal of Physiology - Endocrinology and Metabolism. 295:E658-E664. 2008
- ACE inhibitors: back to prime time?. Heart British Heart Journal. 93:1015-1016. 2007
- Patient Characteristics, Compliance, and Exercise Outcomes of South Asians Enrolled in Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation Journal of Cardiopulmonary Rehabilitation and Prevention. 27:212-218. 2007
- Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial). American Journal of Cardiology. 99:1538-1543. 2007
- South Asians and Cardiovascular Risk. Circulation. 113:e924-e929. 2006
- Non-ST segment elevation acute coronary syndromes: A simplified risk-oriented algorithm. Canadian Journal of Cardiology. 22:663-677. 2006
- Is South Asian ethnicity an independent cardiovascular risk factor?. Canadian Journal of Cardiology. 22:193-197. 2006
- Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?. Nature Clinical Practice Cardiovascular Medicine. 2:124-125. 2005
- Clinical characteristics of South Asian patients hospitalized with heart failure.. Ethnicity and Disease. 15:615-619. 2005
- Angina pectoris presenting as headache.. Indian Heart Journal. 56:685-686. 2004
- International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2. European Heart Journal. 24:1640-1650. 2003
- Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.. Canadian Journal of Cardiology. 18:1179-1190. 2002
- Myocardial infarction in South Asians - Four of the authors respond. CMAJ. 167:454-455. 2002
- Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects.. CMAJ. 166:717-722. 2002
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 21:2033-2041. 2000
- Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States. Canadian Journal of Cardiology. 16:1231-1239. 2000
- Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.. Canadian Journal of Cardiology. 16:1231-1239. 2000
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet. 355:253-259. 2000
- Impact and inequity of inpatient waiting times for advanced cardiovascular services in community hospitals across the greater Toronto area.. Canadian Journal of Cardiology. 15:777-782. 1999
- The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.. Canadian Journal of Cardiology. 12:127-137. 1996
- COLLABORATIVE CARDIOVASCULAR CLINICAL-TRIALS IN CANADA. Canadian Journal of Cardiology. 11:649-657. 1995
- Are hepatic pulsations in dilated cardiomyopathy with heart failure due to tricuspid regurgitation?. American Journal of Cardiology. 71:355-358. 1993
- Disappearance of Q waves following thrombolysis for acute myocardial infarction.. Canadian Journal of Cardiology. 8:1063-1065. 1992
- The Mechanisms and Importance of Tricuspid Regurgitation and Hepatic Pulsations in Dilated Cardiomyopathy: A Review. Echocardiography. 8:195-206. 1991
-
conference paper
- Canadian Definition for Familial Hypercholesterolemia. Atherosclerosis Supplements. 55-56. 2018
- WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY. Journal of the American College of Cardiology. 521-521. 2018
- FACTORS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY. Journal of the American College of Cardiology. A520-A520. 2018
- Do atrial fibrillation patients with history of cerebrovascular accidents receive guideline-concordant stroke preventive therapies? Insights from the prospective SPRINT-AF registry. European Heart Journal. 82-83. 2017
- CONCOMITANT USE OF ANTIPLATELET AND ORAL ANTICOAGULATION AMONG PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY. Journal of the American College of Cardiology. 452-452. 2017
- A Cross Canada Assessment of Management of Patients with a History of TIA or Stroke Related to Atrial Fibrillation. Insights From SPRINT-AF Registry. International Journal of Stroke. 4-4. 2016
- Deterioration of glycemic control in South Asians vs. White Caucasians with diabetes and concomitant coronary artery disease analysis from the PRACTICE Registry. European Heart Journal. 121-122. 2015
- HIGH RATE OF PROGRESSION TO DYSGLYCEMIA IN A SECONDARY PREVENTION COHORT OVER FIVE YEARS: FINDINGS FROM THE PRACTICE REGISTRY. Journal of the American College of Cardiology. A1605-A1605. 2015
- UNDERUSE OF FULL DOSE FACTOR XA INHIBITION IN ATRIAL FIBRILLATION: INSIGHT FROM THE SPRINT-AF REGISTRY. Journal of the American College of Cardiology. A348-A348. 2015
- DISAGREEMENT BETWEEN PHYSICIAN-REPORTED AND SCORING SYSTEM-BASED STROKE AND BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY. Journal of the American College of Cardiology. A423-A423. 2014
- FACTORS ASSOCIATED WITH NEW ORAL ANTICOAGULANT VERSUS VITAMIN K ANTAGONIST USE IN A CONTEMPORARY, NATIONAL, REAL-WORLD OBSERVATIONAL REGISTRY: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY. Journal of the American College of Cardiology. A331-A331. 2014
- Prevalence of Impaired Fasting Glucose in Healthy Middle-Aged Adults: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012
- Prevalence of Metabolic Syndrome in Healthy Middle-Aged Adults: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012
- Variability in Traditional and Novel Cardiovascular Risk Factors by Ethnic Origin: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012
- MicroRNA-145 Targeted Therapy Reduces Atherosclerosis. Circulation. S81-S90. 2012
- CONTEMPORARY MANAGEMENT AND CONTROL OF UNCOMPLICATED HYPERTENSION: INSIGHTS FROM THE PRIMARY CARE AUDIT OF GLOBAL RISK MANAGEMENT (PARADIGM) STUDY. Journal of the American College of Cardiology. E1724-E1724. 2012
- Prolonged Cardiovascular System Failure in South Asians Undergoing Cardiopulmonary Bypass Correlates with Prolonged Inflammation and Increased TLR4-Mediated Signaling. Circulation. 2011
- Who Receives ASA for Primary Prevention in Canada?: Insight From the PRIMARY CARE AUDIT OF GLOBAL RISK MANAGEMENT (PARADIGM) Study. Circulation. 2011
- CARDIOVASCULAR (CV) RISK STRATIFICATION BY PRIMARY CARE PHYSICIANS (PCPS) USING FRAMINGHAM RISK SCORE (FRS) AND IN-OFFICE CAROTID ULTRASOUND: PRELIMINARY RESULTS FROM THE PRIMARY CARE AUDIT OF GLOBAL RISK MANAGEMENT (PARADIGM) STUDY. Journal of the American College of Cardiology. E548-E548. 2011
- COMPARATIVE EVALUATION OF ADIPOKINES, INFLAMMATORY MARKERS AND CARDIOVASCULAR OUTCOMES IN ASIAN INDIANS VS. EUROPEAN WHITES WITH CORONARY HEART DISEASE: RESULTS FROM THE PRACTICE REGISTRY. Journal of the American College of Cardiology. E1424-E1424. 2011
- Accuracy of Cardiovascular (cv) Risk Stratification by Canadian Primary Care Physicians: Preliminary Results From the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2010
- ADIPONECTIN PRIMES HUMAN MONOCYTES INTO ALTERNATIVE M2 MACROPHAGES: A NOVEL MECHANISM OF OBESITY-INDUCED ATHEROSCLEROSIS. Canadian Journal of Cardiology. 109D-109D. 2010
- BRCA1 IMPROVES ENDOTHELIAL FUNCTION AND LIMITS ATHEROSCLEROSIS. Canadian Journal of Cardiology. 120D-120D. 2010
- FIBRINOLYTIC FUNCTION IN SOUTH ASIANS AND EUROPEANS WITH CORONARY HEART DISEASE: INSIGHTS FROM THE PRACTICE REGISTRY. Canadian Journal of Cardiology. 57D-57D. 2010
- PLASMA RENIN ACTIVITY PREDICTS CARDIOVASCULAR EVENTS AND MORTALITY IN THE HEART OUTCOMES PREVENTION EVALUATION (HOPE) STUDY. Canadian Journal of Cardiology. 76D-76D. 2010
- ROSIGLITAZONE-BASED THERAPY REDUCES INFLAMMATORY BIOMARKERS IN DIABETIC, HYPERTENSIVE PATIENTS COMPARED TO A METFORMIN AND GLYBURIDE BASED-REGIMEN: THE ROSITEL RANDOMIZED TRIAL. Canadian Journal of Cardiology. 125D-125D. 2010
- Adropin Is a Novel Regulator of Endothelial Function. Circulation. S185-S192. 2010
- Plasma Renin Activity is Associated With Increased Cardiovascular Events and Mortality in the HOPE Study. Circulation. S453-S453. 2009
- Trends in Contemporary Cardiovascular Risk Assessment in Canada: Results of the PARADIGM Perceptions Study. Circulation. S411-S412. 2009
- Adiponectin Deficiency Profoundly Exacerbates Sepsis-Related Mortality through Endothelial Activation: A Novel Mechanistic Link between Adiposity and Sepsis. Circulation. S1168-S1168. 2008
- Health status and quality of life outcomes in south Asian and European Canadians with coronary artery disease. Circulation. E454-E454. 2008
- Prevalence and gender distribution of metabolic syndrome in South Asians and white Caucasians with coronary heart disease. Canadian Journal of Cardiology. 188C-188C. 2007
- PO23-732 LDL-C AND CRP LOWERING WITH ATORVASTATIN IN SOUTH ASIANS AND CAUCASIANS: INSIGHTS FROM THE ACTFAST STUDY. Atherosclerosis Supplements. 195-195. 2007
- Elevated skin cholesterol (STC) and C-reactive protein (CRP) are associated with increased prevalence of metabolic syndrome (MS) in high risk subjects. Arteriosclerosis, Thrombosis, and Vascular Biology. E85-E85. 2006
- Cardiomyopathy results in reduced endocardial thrombomodulin expression and decreased activated protein C activity. Circulation. 175-175. 2004
- 1153-67 Patient attitudes in clinical trials: The PACT survey. Journal of the American College of Cardiology. A416-A416. 2004
- Impact of South Asian (SA) ethnicity on presentation and outcomes following hospitalization for congestive heart failure (CHF). Journal of the American College of Cardiology. 193A-194A. 2002
- Differences in presentation and 1 year outcomes in coronary artery disease (CAD) patients of South Asian vs European ethnicity treated in an outpatient cardiology practice. Journal of the American College of Cardiology. 376A-376A. 2001
- International differences in in-hospital revascularization and outcomes following acute myocardial infarction (AMI) in ASSENT-2. Circulation. 434-434. 2000
- Impact of temporal trends in management on outcomes of acute myocardial infarction in Canada versus US. Circulation. 479-479. 1998